Previous Article | Next Article 
J Virol, April 1998, p. 2935-2944, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Functional Analysis of the Human Immunodeficiency
Virus Type 1 Rev Protein Oligomerization Interface
Sarah L.
Thomas,1
Martin
Oft,2
Herbert
Jaksche,1
Georg
Casari,3
Peter
Heger,4
Marika
Dobrovnik,1
Dorian
Bevec,1 and
Joachim
Hauber1,*
Department of Immunology, Novartis Research
Institute, A-1235 Vienna,1 and
Research
Institute of Molecular Pathology, A-1030
Vienna,2 Austria, and
Department of
Biocomputing, EMBL, D-69117 Heidelberg,3 and
Institute for Clinical and Molecular Virology, University
of Erlangen-Nürnberg, D-91054 Erlangen,4
Germany
Received 16 June 1997/Accepted 22 December 1997
The expression of human immunodeficiency virus type 1 (HIV-1)
structural proteins requires the action of the viral
trans-regulatory protein Rev. Rev is a nuclear shuttle
protein that directly binds to its cis-acting Rev response
element (RRE) RNA target sequence. Subsequent oligomerization of Rev
monomers on the RRE and interaction of Rev with a cellular cofactor(s)
result in the cytoplasmic accumulation of RRE-containing viral mRNAs.
Moreover, Rev by itself is exported from the nucleus to the cytoplasm.
Although it has been demonstrated that Rev multimerization is
critically required for Rev activity and hence for HIV-1 replication,
the number of Rev monomers required to form a
trans-activation-competent complex on the RRE is unknown. Here we report a systematic analysis of the putative multimerization domains within the Rev trans-activator protein. We identify
the amino acid residues which are part of the proposed single
hydrophobic surface patch in the Rev amino terminus that mediates
intermolecular interactions. Furthermore, we show that the expression
of a multimerization-deficient Rev mutant blocks
HIV-1 replication in a trans-dominant (dominant-negative) fashion.
*
Corresponding author. Present address: Institute for
Clinical and Molecular Virology, University of Erlangen-Nürnberg,
Schlossgarten 4, D-91054 Erlangen, Germany. Phone: 49-9131-85 6182. Fax: 49-9131-85 2101. E-mail:
jmhauber{at}viro.med.uni-erlangen.de
This article has been cited by other articles:
-
Svicher, V., Alteri, C., D'Arrigo, R., Lagana, A., Trignetti, M., Lo Caputo, S., Callegaro, A. P., Maggiolo, F., Mazzotta, F., Ferro, A., Dimonte, S., Aquaro, S., di Perri, G., Bonora, S., Tommasi, C., Trotta, M. P., Narciso, P., Antinori, A., Perno, C. F., Ceccherini-Silberstein, F.
(2009). Treatment with the Fusion Inhibitor Enfuvirtide Influences the Appearance of Mutations in the Human Immunodeficiency Virus Type 1 Regulatory Protein Rev. Antimicrob. Agents Chemother.
53: 2816-2823
[Abstract]
[Full Text]
-
Arnold, M., Nath, A., Hauber, J., Kehlenbach, R. H.
(2006). Multiple Importins Function as Nuclear Transport Receptors for the Rev Protein of Human Immunodeficiency Virus Type 1. J. Biol. Chem.
281: 20883-20890
[Abstract]
[Full Text]
-
Lischka, P., Toth, Z., Thomas, M., Mueller, R., Stamminger, T.
(2006). The UL69 Transactivator Protein of Human Cytomegalovirus Interacts with DEXD/H-Box RNA Helicase UAP56 To Promote Cytoplasmic Accumulation of Unspliced RNA.. Mol. Cell. Biol.
26: 1631-1643
[Abstract]
[Full Text]
-
Trikha, R., Brighty, D. W.
(2005). Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells. J. Gen. Virol.
86: 1509-1513
[Abstract]
[Full Text]
-
Daelemans, D., Costes, S. V., Cho, E. H., Erwin-Cohen, R. A., Lockett, S., Pavlakis, G. N.
(2004). In Vivo HIV-1 Rev Multimerization in the Nucleolus and Cytoplasm Identified by Fluorescence Resonance Energy Transfer. J. Biol. Chem.
279: 50167-50175
[Abstract]
[Full Text]
-
Hartlieb, B., Modrof, J., Muhlberger, E., Klenk, H.-D., Becker, S.
(2003). Oligomerization of Ebola Virus VP30 Is Essential for Viral Transcription and Can Be Inhibited by a Synthetic Peptide. J. Biol. Chem.
278: 41830-41836
[Abstract]
[Full Text]
-
Hakata, Y., Yamada, M., Mabuchi, N., Shida, H.
(2002). The Carboxy-Terminal Region of the Human Immunodeficiency Virus Type 1 Protein Rev Has Multiple Roles in Mediating CRM1-Related Rev Functions. J. Virol.
76: 8079-8089
[Abstract]
[Full Text]
-
Nam, Y.-S., Petrovic, A., Jeong, K.-S., Venkatesan, S.
(2001). Exchange of the Basic Domain of Human Immunodeficiency Virus Type 1 Rev for a Polyarginine Stretch Expands the RNA Binding Specificity, and a Minimal Arginine Cluster Is Required for Optimal RRE RNA Binding Affinity, Nuclear Accumulation, and trans-Activation. J. Virol.
75: 2957-2971
[Abstract]
[Full Text]
-
D'Agostino, D. M., Ferro, T., Zotti, L., Meggio, F., Pinna, L. A., Chieco-Bianchi, L., Ciminale, V.
(2000). Identification of a Domain in Human Immunodeficiency Virus Type 1 Rev That Is Required for Functional Activity and Modulates Association with Subnuclear Compartments Containing Splicing Factor SC35. J. Virol.
74: 11899-11910
[Abstract]
[Full Text]
-
Rosorius, O., Fries, B., Stauber, R. H., Hirschmann, N., Bevec, D., Hauber, J.
(2000). Human Ribosomal Protein L5 Contains Defined Nuclear Localization and Export Signals. J. Biol. Chem.
275: 12061-12068
[Abstract]
[Full Text]
-
Heger, P., Rosorius, O., Koch, C., Casari, G., Grassmann, R., Hauber, J.
(1998). Multimer Formation Is Not Essential for Nuclear Export of Human T-Cell Leukemia Virus Type 1 Rex trans-Activator Protein. J. Virol.
72: 8659-8668
[Abstract]
[Full Text]